학술논문
GA101, a Novel Humanized Type II CD20 Antibody with Glycoengineered Fc and Enhanced Cell Death Induction, Exhibits Superior Anti-Tumor Efficacy and Superior Tissue B Cell Depletion In Vivo.
Document Type
Abstract
Author
Umana, Pablo ; Ekkehard, Moessner ; Peter, Bruenker ; Gabriele, Klingner ; Ursula, Puentener ; Suter, Tobias ; Grau, Roger ; Schmidt, Carla ; Herter, Sylvia ; Gerdes, Christian ; Nopora, Adam ; Patre, Monika ; Moser, Samuel ; Sondermann, Peter ; Wheat, Luise ; Dyer, Martin J.S.; Poppema, Sibrand ; Bauer, Sabine ; Kubbies, Manfred ; Strein, Pamela ; Fertig, Georg ; Friess, Thomas ; Dabbagh, Karim ; DalPorto, Joe ; Klein, Christian
Source
In Blood 16 November 2007 110(11):2348-2348
Subject
Language
ISSN
0006-4971